Cancers, Volume 17, Issue 20
2025 October-2 - 118 articles
Cover Story: The urokinase-type plasminogen activator receptor (uPAR) regulates extracellular proteolysis, cell adhesion, migration, and tissue remodeling. In cancer, uPAR is frequently overexpressed, where it promotes invasion, metastatic spread, angiogenesis, and reshaping of the tumor microenvironment through interactions with uPA, integrins, vitronectin, and EGFR signaling. uPAR also contributes to immune cell recruitment and macrophage polarization, supporting a pro-invasive and immunosuppressive tumor environment. Circulating suPAR reflects systemic inflammatory and disease activity states. Increasing insight into uPAR biology has led to diagnostic applications and emerging therapeutic strategies, including monoclonal antibodies, uPA-derived peptides, and small-molecule antagonists. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.